TXP Medical to Support RWD Study of Acute Stage Conducted by Otsuka

TXP Medical to Support RWD Study of Acute Stage Conducted by Otsuka_OGP

TXP Medical Co. Ltd (CEO: Tomohiro Sonoo, hereinafter "TXP Medical") has initiated to support Real World Data (RWD) study (hereafter "the study") conducted by Otsuka Pharmaceutical Co., Ltd.("Otsuka") to investigate the patient background and actual drug use.

This study aims to clarify risk factors in the perioperative period by analyzing patient background, intraoperative events, and clinical outcomes using RWD derived from electronic medical records at multiple medical institutions. The RWD used in this study is standardized and structured time-series clinical test values, surgery-related data, and ICU treatment-related data provided by TXP Medical’s system. By clarifying the current treatment status of target diseases, TXP Medical and Otsuka will contribute to improving clinical outcomes and quality of life for patients.

<Details of research support>
This study will analyze patient data from each hospital to investigate background factors, surgical procedures, and events in target patients. TXP Medical analyzes RWD, which includes standardized and structured lab data and various scores, with the knowledge of ER and ICU medical doctors.

[Features of TXP Medical's RWD Service]
TXP Medical's RWD service consistently supports the study design proposal, statistical analysis plan preparation, data provision, and analysis. The study's required statistics, including diagnosis name, date of onset, treatment pattern, and laboratory values, are collected and analyzed in detail under the supervision of TXP Medical's medical doctors.

[About TXP Medical]
TXP Medical is a healthcare IT start-up company established by an emergency and critical care physician with the mission of "Saving lives with medical data." We have been working on improving patient experience and boosting the productivity of healthcare professionals in emergency departments in hospitals through enhancing digital transformation with AI-based technologies..

CEO: Tomohiro Sonoo (Emergency and Critical Care Physician)
Established: August 28, 2017
Web: txpmedical.jp/en

・Development and provision of the NEXT Stage series, a medical data system that accelerates digitalization in acute care and community healthcare
・Development and provision of medical AI technology supporting clinical research
・Development of a medical data platform
・Creation of new value through the utilization of medical data

ALL NEWS

Products